rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2004-7-12
|
pubmed:abstractText |
Analogues of bombesin have been synthesized in which a N2S2 (bis-mercaptoacetyl functionalized diaminopropionic acid) or a N3S (mercaptoacetyl-Gly-Gly-Gly) radiometal-chelating center has been incorporated that allows radiolabeling of these peptides with 99mTc without the need for conjugation or harsh reaction conditions. A mild radiolabeling is possible by using an acetyl-moiety as sulfur protecting group, which can be removed by mild hydroxylamine-treatment at room temperature before radiolabeling. Retained receptor binding is demonstrated in competitive binding experiments with 99mTc-radiolabeled peptides and PC-3 cells with bombesin receptors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0969-8051
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2004 Elsevier Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
815-20
|
pubmed:meshHeading |
pubmed-meshheading:15246374-Binding, Competitive,
pubmed-meshheading:15246374-Bombesin,
pubmed-meshheading:15246374-Cell Line, Tumor,
pubmed-meshheading:15246374-Chelating Agents,
pubmed-meshheading:15246374-Drug Stability,
pubmed-meshheading:15246374-Humans,
pubmed-meshheading:15246374-Isotope Labeling,
pubmed-meshheading:15246374-Male,
pubmed-meshheading:15246374-Peptides,
pubmed-meshheading:15246374-Prostatic Neoplasms,
pubmed-meshheading:15246374-Radiopharmaceuticals,
pubmed-meshheading:15246374-Receptors, Bombesin,
pubmed-meshheading:15246374-Spectrometry, Mass, Matrix-Assisted Laser...,
pubmed-meshheading:15246374-Technetium,
pubmed-meshheading:15246374-Technetium Tc 99m Mertiatide
|
pubmed:year |
2004
|
pubmed:articleTitle |
New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides.
|
pubmed:affiliation |
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
|
pubmed:publicationType |
Journal Article
|